Researchers said the new findings add to a small but growing body of evidence that microplastic pollution represents an ...

A drug developed as an antidote to the antiplatelet agent ticagrelor safely and effectively reversed ticagrelor’s antiplatelet effects in patients undergoing urgent surgery or experiencing major ...

In addition to causing several types of cancer, human papillomavirus (HPV) appears to bring a significantly increased risk of heart disease and coronary artery disease, according to a study being ...

The WARRIOR trial showed that among women with suspected INOCA, intensive medical therapy failed to significantly reduce the first occurrence of MACE vs. usual care at 5 years. Symptomatic women with ...

At three months of follow-up, patients hospitalized for a serious heart attack who were treated with the oral blood thinner rivaroxaban for a blood clot in the left ventricle did as well as similar ...

The answer to your heart health may be on your wrist, a new study suggests. Researchers have developed a new way to assess cardiovascular health based on information routinely collected by ...

In this interview, Drs. Richard Chazal and Mikhail Kosiborod explore the rapidly evolving therapeutic landscape of obesity, with a particular focus on the cardiovascular benefits of emerging ...

An intensive three-drug regimen of heart medications did not significantly impact the rate of serious cardiovascular events at five years in women who experienced signs and symptoms of ischemia, or ...

People diagnosed with colorectal cancer are significantly more likely to die of cardiovascular causes than the general population, especially in the first two years after their cancer diagnosis and in ...

Among a cohort of multiethnic participants without baseline cardiovascular disease, the presence of extracoronary calcification (ECC) at baseline was independently associated with an increased risk ...

Patients with spontaneous coronary artery dissection (SCAD) who are discharged on oral anticoagulation (OAC) or dual antiplatelet therapy (DAPT) that combines aspirin plus ticagrelor have a higher ...